The license application process for NMPA (National Medical Products Administration) certification in China involves several key steps. Here’s an overview of the process:
### 1. **Pre-Application Preparation**
- **Device Classification**: Determine the classification of your medical device (Class I, II, or III) based on the risk level to identify the applicable requirements and documentation needed.
- **Compliance Framework**: Ensure compliance with relevant regulations, including ISO 13485 for quality management systems and any applicable GB (Guobiao) standards.
### 2. **Preparation of Documentation**
- **Registration Dossier**: Compile a comprehensive registration dossier, which should include:
- **Product Information**: Detailed description, intended use, specifications, and manufacturing process.
- **Quality Management Documentation**: Evidence of ISO 13485 certification and relevant QA/QC practices.
- **Clinical Data**: For Class II and III devices, a clinical evaluation report and, if necessary, clinical trial data.
- **Risk Management**: Documentation demonstrating compliance with ISO 14971.
### 3. **Selection of a Local Agent**
- **Local Representative**: Foreign manufacturers must appoint a local agent or representative in China who will act on their behalf for all regulatory submissions and communications with the NMPA.
### 4. **Submission of Application**
- **Application Submission**: Submit the registration dossier to the NMPA through the electronic submission system, or submit in person at designated NMPA offices.
- **Payment of Fees**: Pay the applicable registration fees based on the device classification.
### 5. **Review by NMPA**
- **Administrative Review**: The NMPA conducts an initial administrative review to ensure all required documents are submitted and correctly formatted.
- **Technical Review**: A detailed technical evaluation is performed, which may involve:
- Assessment of safety and efficacy based on provided clinical data.
- Review of manufacturing processes and quality management systems.
- **On-Site Inspection**: For Class II and III devices, the NMPA may conduct an on-site inspection of the manufacturing facility to assess compliance with regulatory standards.
### 6. **Approval Process**
- **Approval Decision**: After completing the review process, the NMPA makes a decision to approve or reject the application.
- **Issuance of Medical Device License**: If approved, the NMPA issues a Medical Device Registration Certificate, which is necessary for marketing the device in China.
### 7. **Post-Market Surveillance and Reporting**
- Manufacturers are required to establish a post-market surveillance system to monitor device performance and report any adverse events to the NMPA.
- Periodic renewals are required every five years, along with updates if there are significant changes to the device or manufacturing process.
### 8. **Renewal and Variations**
- **Renewal Application**: Start the renewal process several months before the current registration expires. New documentation may be required.
- **Changes to Registration**: Any modifications to the device (such as changes in manufacturing or specifications) must be reported, and in some cases, a new application may be necessary.
### Timeline
The duration of the approval process can vary:
- **Class I Devices**: Typically, a faster, more streamlined process.
- **Class II and III Devices**: Can take from several months to over a year depending on the complexity of the submission, any required clinical trials, and NMPA's workload.
### Conclusion
Navigating the NMPA certification process can be complex, requiring thorough preparation and understanding of regulatory requirements. Ensuring compliance with local laws and guidelines and maintaining open communication with the NMPA through a local representative can significantly streamline the process. If you have more specific questions or need further details about any step, feel free to ask!
Contact Us:
Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn